Company intelligence
ALK
We are a global allergy solutions company, pioneering in allergy research for more than 100 years.
About ALK
We are the pioneers of allergy solutions. Allergy is the most common chronic disease globally and it has profound impact on people’s lives. More than 500 million people worldwide live with respiratory allergies, more than 200 million people have some sort of food allergy, and more than 100 million children are living with allergic rhinitis. These numbers are only expected to increase, and as a result, the need for allergy solutions is ever-growing. For more than a 100 years, ALK has been at the forefront of long-term allergy treatment. Building on our strong heritage, we are now stepping into the next 100 years with a mission to help even more people, with more solutions, more efficiently. We call it Allergy+. ALK is a global company with production sites in Denmark, France, Spain and the United States. ALK was founded in Copenhagen in 1923 and today we employ around 2,900 people around the world. Our global headquarters is located in beautiful surroundings in Hørsholm, north of Copenhagen. Read more about ALK at www.alk.net
Verified activity
Signals from ALK
4 published signals
People
ALK UK & ROI affiliate has grown from a small sales-focused team to a cross-functional affiliate of around 40 employees with medical affairs, market access, sales, marketing, regulatory affairs, and business support colleagues working side by side in the new Maidenhead office in London.
Reported by ALK
People
ALK appointed Sandra Mortelette as the new Responsable Projets, Validation des Systèmes Informatisés et Excellence Opérationnelle after 9 years in the company.
Reported by ALK
Research & Knowledge
ALK published a FORWARD cohort study of 1,359 children showing that race, income, health literacy, and neighborhood deprivation significantly impact the likelihood of a child outgrowing food allergies.
Reported by Jay Bates
Operations & Supply
ALK facility in Post Falls, Idaho, collects pollen and allergenic source materials from nature before processing them through pharmaceutical processes.
Reported by ALK